custom image

Antibodies and Vaccines as Drugs for COVID-19

January 13-14, 2021 | 9:00AM EST | 2:00PM UTC | 3:00PM CET*
*Program is in development and subject to change


Reset

Advanced Filters
09:00am - 11:40am Eastern - January 13, 2021
David P. Humphreys, Co-Chair, UCB Pharma, UK; Esther Breij, Co-Chair, Genmab
Track: Antibodies as Drugs for COVID‑19

Wednesday
09:00am - 09:15am Eastern - January 13, 2021
Bo Barnhart, PhD, Abcellera Biologics Inc.
Track: Antibodies as Drugs for COVID‑19

Wednesday
09:15am - 09:30am Eastern - January 13, 2021
Christos Kyratsous, PhD, Regeneron Pharmaceuticals Inc
Track: Antibodies as Drugs for COVID‑19

Wednesday
09:30am - 09:45am Eastern - January 13, 2021
Davide Corti, PhD, Humabs BioMed SA
Track: Antibodies as Drugs for COVID‑19

Wednesday
09:45am - 10:00am Eastern - January 13, 2021
X. Sunney Xie, PhD, Peking University
Track: Antibodies as Drugs for COVID‑19

Wednesday
10:00am - 10:25am Eastern - January 13, 2021
Track: Antibodies as Drugs for COVID‑19

Wednesday
10:25am - 10:40am Eastern - January 13, 2021
Linqi Zhang, PhD, Tsinghua University
Track: Antibodies as Drugs for COVID‑19

Wednesday
10:40am - 10:55am Eastern - January 13, 2021
Xavier Saelens, PhD, Ghent University
Track: Antibodies as Drugs for COVID‑19

Wednesday
10:55am - 11:10am Eastern - January 13, 2021
Michael Stumpp, PhD, Molecular Partners
Track: Antibodies as Drugs for COVID‑19

Wednesday
11:10am - 11:25am Eastern - January 13, 2021
Michael G. Ison, MD, Northwestern/Celltrion, Inc.
Track: Antibodies as Drugs for COVID‑19

09:00am - 11:35am Eastern - January 14, 2021
Pierre Bruhns, Co-Chair, Institut Pasteur; David P. Humphreys, Co-Chair, UCB Pharma, UK
Track: Vaccines as Drugs for COVID‑19

Thursday
09:00am - 09:15am Eastern - January 14, 2021
Liise-anne Pirofski, MD, Albert Einstein College of Medicine and Montefiore Medical Center
Track: Vaccines as Drugs for COVID‑19

Thursday
09:15am - 09:30am Eastern - January 14, 2021
Paul F. McKay, PhD, Imperial College
Track: Vaccines as Drugs for COVID‑19

Thursday
09:30am - 09:45am Eastern - January 14, 2021
Track: Vaccines as Drugs for COVID‑19

Thursday
09:45am - 10:00am Eastern - January 14, 2021
Track: Vaccines as Drugs for COVID‑19

Thursday
10:00am - 10:15am Eastern - January 14, 2021
Track: Vaccines as Drugs for COVID‑19

Thursday
10:15am - 10:30am Eastern - January 14, 2021
Sarah Catherine Gilbert, PhD, University of Oxford
Track: Vaccines as Drugs for COVID‑19

Thursday
10:30am - 10:45am Eastern - January 14, 2021
Track: Vaccines as Drugs for COVID‑19

Thursday
10:45am - 11:00am Eastern - January 14, 2021
Hanneke Schuitemaker, PhD, Janssen Vaccines & Prevention B.V.
Track: Vaccines as Drugs for COVID‑19

Thursday
11:00am - 11:15am Eastern - January 14, 2021
Susanne Rauch, CureVac GmbH
Track: Vaccines as Drugs for COVID‑19

Thursday

Thursday
11:30am - 11:35am Eastern - January 14, 2021
Track: Vaccines as Drugs for COVID‑19